scispace - formally typeset
T

Takao Miyata

Researcher at Kumamoto University

Publications -  11
Citations -  3358

Takao Miyata is an academic researcher from Kumamoto University. The author has contributed to research in topics: Insulin & Bradykinin receptor. The author has an hindex of 6, co-authored 11 publications receiving 3261 citations.

Papers
More filters
Journal ArticleDOI

Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study.

TL;DR: In conclusion, intensive glycemic control by multiple insulin injection therapy can delay the onset and the progression of diabetic retinopathy, nephropathy and neuropathy in Japanese patients with NIDDM.
Journal Article

Development of a ferrocene-mediated needle-type glucose sensor covered with newly designed biocompatible membrane, 2-methacryloyloxyethyl phosphorylcholine-co-n-butyl methacrylate.

TL;DR: The ferrocene-mediated needle-type glucose sensor covered with poly(MPC-co-BMA) membrane achieved excellent results in vitro, and it is concluded that this sensor is stable and reliable, as compared to any other glucose sensors developed.
Journal ArticleDOI

Effect on insulin sensitivity of angiotensin converting enzyme inhibitors with or without a sulphydryl group: Bradykinin may improve insulin resistance in dogs and humans

TL;DR: It is concluded that ACE inhibitors with a sulphydryl group have more potent action on the improvement in insulin sensitivity than those without a sulphytol group.
Journal ArticleDOI

Bradykinin potentiates insulin-stimulated glucose uptake and enhances insulin signal through the bradykinin B2 receptor in dog skeletal muscle and rat L6 myoblasts

TL;DR: It is concluded that bradykinin could potentiate the insulin-induced glucose uptake through GLUT4 translocation in dog skeletal muscle and rat L6 myoblasts.
Journal ArticleDOI

Effect of α2-adrenoceptor antagonist on platelet activation during insulin-induced hypoglycaemia in Type 2 (non-insulin-dependent) diabetes mellitus

TL;DR: It is suggested that plasma epinephrine plays an important role in platelet activation during hypoglycaemia in Type 2 diabetes mellitus, and that the plateletactivation is prevented by α2-adrenoceptor antagonist.